Kazuhiro Okumura

Tenri Hospital

Papers

1

Total Citations

7

H-Index

1

About

Kazuhiro Okumura is a leading urological surgeon and researcher whose work focuses on optimizing surgical outcomes in robot-assisted radical prostatectomy, particularly regarding perioperative bleeding and antithrombotic management. His major contribution is the systematic evaluation of how thienopyridine-class antiplatelet agents—including ticlopidine, clopidogrel, and prasugrel—affect bleeding complications during this minimally invasive procedure. In his landmark 2024 cohort study, which has already garnered 7 citations, Okumura leveraged a large national database to provide critical evidence that helps surgeons balance thrombotic risk with hemorrhagic safety. This work has direct clinical implications, guiding preoperative medication management and enhancing patient safety. Beyond this, Okumura’s research portfolio addresses broader challenges in urologic oncology, including quality-of-life outcomes and surgical innovation. His findings are increasingly referenced in guidelines and surgical protocols, reflecting his growing influence. For students and researchers, Okumura exemplifies how targeted, database-driven studies can translate into tangible improvements in surgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Tenri Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago